Marion Mc Court Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

REGN Quotes by TradingView

Marion Mc Court is EVP Commercial of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 12,931 shares of REGN, which is worth approximately $9.69 Million. The most recent transaction as insider was on Nov 01, 2022, when has been sold 1,100 shares (Common Stock) at a price of $372.46 per share, resulting in proceeds of $409,706. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.9K
0% 3M change
34.7% 12M change
Total Value Held $9.69 Million

Marion McCourt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2022
BUY
Exercise of conversion of derivative security
$409,706 $372.46 p/Share
1,100 Added 5.04%
20,744 Common Stock
Oct 03 2022
SELL
Open market or private sale
$775,929 $705.39 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
Oct 03 2022
BUY
Exercise of conversion of derivative security
$393,459 $357.69 p/Share
1,100 Added 5.18%
20,144 Common Stock
Sep 01 2022
SELL
Open market or private sale
$635,382 $577.62 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
Sep 01 2022
BUY
Exercise of conversion of derivative security
$377,223 $342.93 p/Share
1,100 Added 5.04%
20,744 Common Stock
Aug 01 2022
SELL
Open market or private sale
$639,683 $581.53 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
Aug 01 2022
BUY
Exercise of conversion of derivative security
$377,223 $342.93 p/Share
1,100 Added 5.04%
20,744 Common Stock
Jul 01 2022
SELL
Open market or private sale
$646,536 $587.76 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
Jul 01 2022
BUY
Exercise of conversion of derivative security
$377,223 $342.93 p/Share
1,100 Added 5.04%
20,744 Common Stock
Jun 01 2022
SELL
Open market or private sale
$736,461 $669.51 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
Jun 01 2022
BUY
Exercise of conversion of derivative security
$377,223 $342.93 p/Share
1,100 Added 5.04%
20,744 Common Stock
May 02 2022
SELL
Open market or private sale
$722,667 $656.97 p/Share
1,100 Reduced 5.3%
19,644 Common Stock
May 02 2022
BUY
Exercise of conversion of derivative security
$377,223 $342.93 p/Share
1,100 Added 5.04%
20,744 Common Stock
Apr 01 2022
SELL
Open market or private sale
$701,820 $701.82 p/Share
1,000 Reduced 4.84%
19,644 Common Stock
Apr 01 2022
BUY
Exercise of conversion of derivative security
$342,930 $342.93 p/Share
1,000 Added 4.62%
20,644 Common Stock
Mar 01 2022
SELL
Open market or private sale
$615,390 $615.39 p/Share
1,000 Reduced 4.84%
19,644 Common Stock
Mar 01 2022
BUY
Exercise of conversion of derivative security
$342,930 $342.93 p/Share
1,000 Added 4.62%
20,644 Common Stock
Feb 01 2022
SELL
Open market or private sale
$607,460 $607.46 p/Share
1,000 Reduced 4.84%
19,644 Common Stock
Feb 01 2022
BUY
Exercise of conversion of derivative security
$342,930 $342.93 p/Share
1,000 Added 4.62%
20,644 Common Stock
Jan 03 2022
SELL
Open market or private sale
$625,000 $625.0 p/Share
1,000 Reduced 4.84%
19,644 Common Stock
Jan 03 2022
BUY
Exercise of conversion of derivative security
$342,930 $342.93 p/Share
1,000 Added 4.62%
20,644 Common Stock
Dec 13 2021
SELL
Open market or private sale
$224,673 $653.12 p/Share
344 Reduced 1.72%
19,644 Common Stock
Dec 11 2021
SELL
Payment of exercise price or tax liability
$257,764 $664.34 p/Share
388 Reduced 1.9%
19,988 Common Stock
Dec 08 2021
BUY
Grant, award, or other acquisition
-
3,338 Added 14.08%
20,376 Common Stock
Dec 01 2021
SELL
Open market or private sale
$639,130 $639.13 p/Share
1,000 Reduced 5.54%
17,038 Common Stock
MM

Marion Mc Court

EVP Commercial
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on REGN